HEADER OXIDOREDUCTASE 11-JAN-08 2VL9 TITLE OXIDIZED FORM OF HUMAN PEROXIREDOXIN 5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXIREDOXIN-5; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: RESIDUES 2-162; COMPND 5 SYNONYM: PRX-V, PEROXISOMAL ANTIOXIDANT ENZYME, PLP, THIOREDOXIN COMPND 6 REDUCTASE, THIOREDOXIN PEROXIDASE PMP20, ANTIOXIDANT ENZYME B166, COMPND 7 AOEB166, TPX TYPE VI, LIVER TISSUE 2D-PAGE SPOT 71B, ALU COREPRESSOR COMPND 8 1, HUMAN PEROXIREDOXIN 5; COMPND 9 EC: 1.11.1.15; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: LUNG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI M15; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1007065; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PQE-30 KEYWDS THIOREDOXIN PEROXIDASE, ALTERNATIVE INITIATION, ANTIOXIDANT ENZYME, KEYWDS 2 REDOX-ACTIVE CENTER, CYTOPLASM, PEROXIDASE, PEROXISOME, ANTIOXIDANT, KEYWDS 3 POLYMORPHISM, MITOCHONDRION, PEROXIREDOXIN, OXIDOREDUCTASE, TRANSIT KEYWDS 4 PEPTIDE, THIOREDOXIN FOLD EXPDTA X-RAY DIFFRACTION AUTHOR A.SMEETS,J.P.DECLERCQ REVDAT 3 24-OCT-18 2VL9 1 SOURCE REVDAT 2 24-FEB-09 2VL9 1 VERSN REVDAT 1 26-AUG-08 2VL9 0 JRNL AUTH A.SMEETS,C.MARCHAND,D.LINARD,B.KNOOPS,J.P.DECLERCQ JRNL TITL THE CRYSTAL STRUCTURES OF OXIDIZED FORMS OF HUMAN JRNL TITL 2 PEROXIREDOXIN 5 WITH AN INTRAMOLECULAR DISULFIDE BOND JRNL TITL 3 CONFIRM THE PROPOSED ENZYMATIC MECHANISM FOR ATYPICAL 2-CYS JRNL TITL 4 PEROXIREDOXINS. JRNL REF ARCH.BIOCHEM.BIOPHYS. V. 477 98 2008 JRNL REFN ISSN 0003-9861 JRNL PMID 18489898 JRNL DOI 10.1016/J.ABB.2008.04.036 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 18076 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 923 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 170.4 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.500 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 79.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.42570 REMARK 3 B22 (A**2) : -6.42570 REMARK 3 B33 (A**2) : 12.66030 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: 0.4790 REMARK 3 OPERATOR: -K,H+K,L REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4836 REMARK 3 ANGLE : 1.636 6539 REMARK 3 CHIRALITY : 0.104 760 REMARK 3 PLANARITY : 0.007 853 REMARK 3 DIHEDRAL : 19.569 1766 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TWIN RATIO IS 50%. COMPUTED STRUCTURE REMARK 3 FACTORS ARE NOT DIRECTLY COMPARABLE TO THE DEPOSITED OBSERVED REMARK 3 STRUCTURE FACTORS. REMARK 4 REMARK 4 2VL9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1290034956. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979764 REMARK 200 MONOCHROMATOR : FIRST CRYSTAL FLAT AND N2 REMARK 200 COOLED. SECOND ONE SAGITALLY BENT REMARK 200 OPTICS : TWO MIRRORS ARE USED FOR REMARK 200 VERTICAL FOCUSSING REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18076 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 46.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 4.050 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.05 REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1OC3 REMARK 200 REMARK 200 REMARK: THE MODEL USED FOR THE MOLECULAR REPLACEMENT WAS A REMARK 200 SIMULATION CREATED FROM PDB ENTRY 1OC3 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000 20% SODIUM CACODYLATE 0.1 M REMARK 280 PH 6.5 SODIUM ACETATE 0.1 M 6-AMINOCAPROIC ACID 3% W/V REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.41800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 128.83600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 128.83600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 64.41800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4570 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 73 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 73 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN C, CYS 73 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN D, CYS 73 TO SER REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -11 REMARK 465 ARG A -10 REMARK 465 GLY A -9 REMARK 465 SER A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET B -11 REMARK 465 ARG B -10 REMARK 465 GLY B -9 REMARK 465 SER B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET C -11 REMARK 465 ARG C -10 REMARK 465 GLY C -9 REMARK 465 SER C -8 REMARK 465 HIS C -7 REMARK 465 HIS C -6 REMARK 465 HIS C -5 REMARK 465 HIS C -4 REMARK 465 HIS C -3 REMARK 465 HIS C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 MET D -11 REMARK 465 ARG D -10 REMARK 465 GLY D -9 REMARK 465 SER D -8 REMARK 465 HIS D -7 REMARK 465 HIS D -6 REMARK 465 HIS D -5 REMARK 465 HIS D -4 REMARK 465 HIS D -3 REMARK 465 HIS D -2 REMARK 465 GLY D -1 REMARK 465 SER D 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO B 45 N PRO B 45 CA -0.117 REMARK 500 GLY B 46 CA GLY B 46 C -0.216 REMARK 500 GLY B 46 C GLY B 46 O 0.175 REMARK 500 ALA D 154 C ALA D 154 O 0.127 REMARK 500 ALA D 154 C PRO D 155 N -0.133 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 45 CB - CA - C ANGL. DEV. = -22.3 DEGREES REMARK 500 PRO B 45 N - CA - C ANGL. DEV. = 31.2 DEGREES REMARK 500 GLY B 46 N - CA - C ANGL. DEV. = 29.7 DEGREES REMARK 500 GLY B 46 CA - C - O ANGL. DEV. = 16.6 DEGREES REMARK 500 CYS B 47 N - CA - CB ANGL. DEV. = -18.3 DEGREES REMARK 500 CYS B 47 N - CA - C ANGL. DEV. = 33.4 DEGREES REMARK 500 SER C 48 CB - CA - C ANGL. DEV. = -18.1 DEGREES REMARK 500 SER C 48 N - CA - C ANGL. DEV. = 30.1 DEGREES REMARK 500 PRO D 2 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 PHE D 15 CB - CA - C ANGL. DEV. = -15.1 DEGREES REMARK 500 LYS D 89 N - CA - C ANGL. DEV. = 16.6 DEGREES REMARK 500 PRO D 155 C - N - CD ANGL. DEV. = -16.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 4 -158.10 -128.40 REMARK 500 ILE A 9 137.76 -39.57 REMARK 500 VAL A 14 -156.71 -110.52 REMARK 500 LYS A 32 123.34 -171.08 REMARK 500 LYS A 49 -6.41 -54.45 REMARK 500 HIS A 51 -160.72 -109.47 REMARK 500 GLU A 57 -19.73 -48.59 REMARK 500 LYS A 65 29.41 -140.67 REMARK 500 GLN A 68 -71.50 -76.52 REMARK 500 ALA A 90 34.26 -92.23 REMARK 500 GLU A 107 22.71 -76.87 REMARK 500 ASP A 109 11.26 57.58 REMARK 500 ASP A 114 11.16 -67.05 REMARK 500 SER A 118 0.70 -59.45 REMARK 500 PHE A 128 -167.68 -175.64 REMARK 500 ASP A 134 -3.04 63.03 REMARK 500 LEU A 140 65.77 -157.24 REMARK 500 ASN A 141 82.94 -67.93 REMARK 500 LEU A 149 52.41 38.14 REMARK 500 ALA A 154 176.95 179.72 REMARK 500 SER A 159 2.26 -69.78 REMARK 500 GLN A 160 126.88 -172.74 REMARK 500 PRO B 2 154.39 -44.13 REMARK 500 PHE B 29 1.60 -150.05 REMARK 500 LYS B 65 15.11 -67.00 REMARK 500 VAL B 67 141.19 -37.12 REMARK 500 LYS B 89 76.70 55.78 REMARK 500 ALA B 90 66.26 -119.71 REMARK 500 PRO B 100 28.51 -78.27 REMARK 500 THR B 101 16.60 -144.34 REMARK 500 GLU B 107 13.74 -65.43 REMARK 500 ASP B 109 -1.61 65.91 REMARK 500 ASP B 113 154.80 -44.79 REMARK 500 ASP B 114 28.32 -75.45 REMARK 500 ARG B 124 157.30 -49.26 REMARK 500 PHE B 128 -153.18 -111.34 REMARK 500 SER B 129 147.37 -177.72 REMARK 500 MET B 130 119.77 -162.25 REMARK 500 ASP B 134 12.34 53.77 REMARK 500 VAL B 137 152.51 -46.95 REMARK 500 LYS B 138 -46.53 -136.04 REMARK 500 LEU B 149 34.98 36.09 REMARK 500 PRO C 2 -168.51 -76.63 REMARK 500 ASP C 7 114.07 -166.84 REMARK 500 ALA C 8 108.60 -56.50 REMARK 500 ILE C 9 126.67 -38.02 REMARK 500 VAL C 14 -155.18 -139.36 REMARK 500 GLU C 16 43.18 -151.06 REMARK 500 GLU C 27 -7.34 -55.54 REMARK 500 LEU C 28 -78.16 -93.67 REMARK 500 REMARK 500 THIS ENTRY HAS 91 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2002 DISTANCE = 8.71 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1URM RELATED DB: PDB REMARK 900 HUMAN PEROXIREDOXIN 5, C47S MUTANT REMARK 900 RELATED ID: 1HD2 RELATED DB: PDB REMARK 900 HUMAN PEROXIREDOXIN 5 REMARK 900 RELATED ID: 1OC3 RELATED DB: PDB REMARK 900 HUMAN PEROXIREDOXIN 5 REMARK 900 RELATED ID: 2VL3 RELATED DB: PDB REMARK 900 OXIDIZED AND REDUCED FORMS OF HUMAN PEROXIREDOXIN 5 REMARK 900 RELATED ID: 2VL2 RELATED DB: PDB REMARK 900 OXIDIZED AND REDUCED FORMS OF HUMAN PEROXIREDOXIN 5 REMARK 900 RELATED ID: 1H4O RELATED DB: PDB REMARK 900 MONOCLINIC FORM OF HUMAN PEROXIREDOXIN 5 DBREF 2VL9 A -11 0 PDB 2VL9 2VL9 -11 0 DBREF 2VL9 A 1 161 UNP P30044 PRDX5_HUMAN 2 162 DBREF 2VL9 B -11 0 PDB 2VL9 2VL9 -11 0 DBREF 2VL9 B 1 161 UNP P30044 PRDX5_HUMAN 2 162 DBREF 2VL9 C -11 0 PDB 2VL9 2VL9 -11 0 DBREF 2VL9 C 1 161 UNP P30044 PRDX5_HUMAN 2 162 DBREF 2VL9 D -11 0 PDB 2VL9 2VL9 -11 0 DBREF 2VL9 D 1 161 UNP P30044 PRDX5_HUMAN 2 162 SEQADV 2VL9 SER A 72 UNP P30044 CYS 73 ENGINEERED MUTATION SEQADV 2VL9 SER B 72 UNP P30044 CYS 73 ENGINEERED MUTATION SEQADV 2VL9 SER C 72 UNP P30044 CYS 73 ENGINEERED MUTATION SEQADV 2VL9 SER D 72 UNP P30044 CYS 73 ENGINEERED MUTATION SEQRES 1 A 173 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ALA SEQRES 2 A 173 PRO ILE LYS VAL GLY ASP ALA ILE PRO ALA VAL GLU VAL SEQRES 3 A 173 PHE GLU GLY GLU PRO GLY ASN LYS VAL ASN LEU ALA GLU SEQRES 4 A 173 LEU PHE LYS GLY LYS LYS GLY VAL LEU PHE GLY VAL PRO SEQRES 5 A 173 GLY ALA PHE THR PRO GLY CYS SER LYS THR HIS LEU PRO SEQRES 6 A 173 GLY PHE VAL GLU GLN ALA GLU ALA LEU LYS ALA LYS GLY SEQRES 7 A 173 VAL GLN VAL VAL ALA SER LEU SER VAL ASN ASP ALA PHE SEQRES 8 A 173 VAL THR GLY GLU TRP GLY ARG ALA HIS LYS ALA GLU GLY SEQRES 9 A 173 LYS VAL ARG LEU LEU ALA ASP PRO THR GLY ALA PHE GLY SEQRES 10 A 173 LYS GLU THR ASP LEU LEU LEU ASP ASP SER LEU VAL SER SEQRES 11 A 173 ILE PHE GLY ASN ARG ARG LEU LYS ARG PHE SER MET VAL SEQRES 12 A 173 VAL GLN ASP GLY ILE VAL LYS ALA LEU ASN VAL GLU PRO SEQRES 13 A 173 ASP GLY THR GLY LEU THR CYS SER LEU ALA PRO ASN ILE SEQRES 14 A 173 ILE SER GLN LEU SEQRES 1 B 173 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ALA SEQRES 2 B 173 PRO ILE LYS VAL GLY ASP ALA ILE PRO ALA VAL GLU VAL SEQRES 3 B 173 PHE GLU GLY GLU PRO GLY ASN LYS VAL ASN LEU ALA GLU SEQRES 4 B 173 LEU PHE LYS GLY LYS LYS GLY VAL LEU PHE GLY VAL PRO SEQRES 5 B 173 GLY ALA PHE THR PRO GLY CYS SER LYS THR HIS LEU PRO SEQRES 6 B 173 GLY PHE VAL GLU GLN ALA GLU ALA LEU LYS ALA LYS GLY SEQRES 7 B 173 VAL GLN VAL VAL ALA SER LEU SER VAL ASN ASP ALA PHE SEQRES 8 B 173 VAL THR GLY GLU TRP GLY ARG ALA HIS LYS ALA GLU GLY SEQRES 9 B 173 LYS VAL ARG LEU LEU ALA ASP PRO THR GLY ALA PHE GLY SEQRES 10 B 173 LYS GLU THR ASP LEU LEU LEU ASP ASP SER LEU VAL SER SEQRES 11 B 173 ILE PHE GLY ASN ARG ARG LEU LYS ARG PHE SER MET VAL SEQRES 12 B 173 VAL GLN ASP GLY ILE VAL LYS ALA LEU ASN VAL GLU PRO SEQRES 13 B 173 ASP GLY THR GLY LEU THR CYS SER LEU ALA PRO ASN ILE SEQRES 14 B 173 ILE SER GLN LEU SEQRES 1 C 173 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ALA SEQRES 2 C 173 PRO ILE LYS VAL GLY ASP ALA ILE PRO ALA VAL GLU VAL SEQRES 3 C 173 PHE GLU GLY GLU PRO GLY ASN LYS VAL ASN LEU ALA GLU SEQRES 4 C 173 LEU PHE LYS GLY LYS LYS GLY VAL LEU PHE GLY VAL PRO SEQRES 5 C 173 GLY ALA PHE THR PRO GLY CYS SER LYS THR HIS LEU PRO SEQRES 6 C 173 GLY PHE VAL GLU GLN ALA GLU ALA LEU LYS ALA LYS GLY SEQRES 7 C 173 VAL GLN VAL VAL ALA SER LEU SER VAL ASN ASP ALA PHE SEQRES 8 C 173 VAL THR GLY GLU TRP GLY ARG ALA HIS LYS ALA GLU GLY SEQRES 9 C 173 LYS VAL ARG LEU LEU ALA ASP PRO THR GLY ALA PHE GLY SEQRES 10 C 173 LYS GLU THR ASP LEU LEU LEU ASP ASP SER LEU VAL SER SEQRES 11 C 173 ILE PHE GLY ASN ARG ARG LEU LYS ARG PHE SER MET VAL SEQRES 12 C 173 VAL GLN ASP GLY ILE VAL LYS ALA LEU ASN VAL GLU PRO SEQRES 13 C 173 ASP GLY THR GLY LEU THR CYS SER LEU ALA PRO ASN ILE SEQRES 14 C 173 ILE SER GLN LEU SEQRES 1 D 173 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ALA SEQRES 2 D 173 PRO ILE LYS VAL GLY ASP ALA ILE PRO ALA VAL GLU VAL SEQRES 3 D 173 PHE GLU GLY GLU PRO GLY ASN LYS VAL ASN LEU ALA GLU SEQRES 4 D 173 LEU PHE LYS GLY LYS LYS GLY VAL LEU PHE GLY VAL PRO SEQRES 5 D 173 GLY ALA PHE THR PRO GLY CYS SER LYS THR HIS LEU PRO SEQRES 6 D 173 GLY PHE VAL GLU GLN ALA GLU ALA LEU LYS ALA LYS GLY SEQRES 7 D 173 VAL GLN VAL VAL ALA SER LEU SER VAL ASN ASP ALA PHE SEQRES 8 D 173 VAL THR GLY GLU TRP GLY ARG ALA HIS LYS ALA GLU GLY SEQRES 9 D 173 LYS VAL ARG LEU LEU ALA ASP PRO THR GLY ALA PHE GLY SEQRES 10 D 173 LYS GLU THR ASP LEU LEU LEU ASP ASP SER LEU VAL SER SEQRES 11 D 173 ILE PHE GLY ASN ARG ARG LEU LYS ARG PHE SER MET VAL SEQRES 12 D 173 VAL GLN ASP GLY ILE VAL LYS ALA LEU ASN VAL GLU PRO SEQRES 13 D 173 ASP GLY THR GLY LEU THR CYS SER LEU ALA PRO ASN ILE SEQRES 14 D 173 ILE SER GLN LEU FORMUL 5 HOH *57(H2 O) HELIX 1 1 GLU A 18 LYS A 22 5 5 HELIX 2 2 LEU A 25 LYS A 30 1 6 HELIX 3 3 CYS A 47 HIS A 51 5 5 HELIX 4 4 GLY A 82 HIS A 88 1 7 HELIX 5 5 GLY A 102 GLU A 107 1 6 HELIX 6 6 LEU A 116 GLY A 121 1 6 HELIX 7 7 ASN A 156 GLN A 160 5 5 HELIX 8 8 CYS B 47 HIS B 51 5 5 HELIX 9 9 LEU B 52 VAL B 56 5 5 HELIX 10 10 GLN B 58 LYS B 63 1 6 HELIX 11 11 ASP B 77 HIS B 88 1 12 HELIX 12 12 GLY B 102 GLU B 107 1 6 HELIX 13 13 LEU B 116 GLY B 121 1 6 HELIX 14 14 ASN B 156 GLN B 160 5 5 HELIX 15 15 LEU C 25 LYS C 30 1 6 HELIX 16 16 LEU C 52 GLU C 57 1 6 HELIX 17 17 GLN C 58 LYS C 63 1 6 HELIX 18 18 ASP C 77 HIS C 88 1 12 HELIX 19 19 GLY C 102 ASP C 109 1 8 HELIX 20 20 SER C 115 PHE C 120 5 6 HELIX 21 21 ASN C 156 GLN C 160 5 5 HELIX 22 22 LEU D 25 LYS D 30 1 6 HELIX 23 23 LEU D 52 GLU D 57 1 6 HELIX 24 24 GLU D 57 LYS D 63 1 7 HELIX 25 25 ALA D 64 GLY D 66 5 3 HELIX 26 26 ASP D 77 GLY D 82 1 6 HELIX 27 27 GLY D 82 ALA D 87 1 6 HELIX 28 28 GLY D 102 GLU D 107 1 6 HELIX 29 29 LEU D 116 GLY D 121 1 6 SHEET 1 AA 2 GLU A 13 VAL A 14 0 SHEET 2 AA 2 VAL A 23 ASN A 24 -1 O VAL A 23 N VAL A 14 SHEET 1 AB 2 ALA A 71 SER A 72 0 SHEET 2 AB 2 ARG A 95 LEU A 96 1 O ARG A 95 N SER A 72 SHEET 1 AC 2 VAL A 132 GLN A 133 0 SHEET 2 AC 2 ILE A 136 VAL A 137 -1 O ILE A 136 N GLN A 133 SHEET 1 BA 2 GLU B 13 VAL B 14 0 SHEET 2 BA 2 VAL B 23 ASN B 24 -1 O VAL B 23 N VAL B 14 SHEET 1 BB 4 VAL B 69 LEU B 73 0 SHEET 2 BB 4 GLY B 34 GLY B 38 1 O VAL B 35 N ALA B 71 SHEET 3 BB 4 PHE B 128 GLN B 133 -1 O PHE B 128 N GLY B 38 SHEET 4 BB 4 ILE B 136 LEU B 140 -1 O ILE B 136 N GLN B 133 SHEET 1 CA 2 GLU C 13 VAL C 14 0 SHEET 2 CA 2 VAL C 23 ASN C 24 -1 O VAL C 23 N VAL C 14 SHEET 1 CB 2 GLY C 34 GLY C 38 0 SHEET 2 CB 2 VAL C 69 LEU C 73 1 O VAL C 69 N VAL C 35 SHEET 1 CC 2 PHE C 128 SER C 129 0 SHEET 2 CC 2 ASN C 141 VAL C 142 -1 O ASN C 141 N SER C 129 SHEET 1 DA 3 VAL D 23 ASN D 24 0 SHEET 2 DA 3 GLU D 13 GLU D 16 -1 O VAL D 14 N VAL D 23 SHEET 3 DA 3 LEU D 97 ALA D 98 -1 O ALA D 98 N PHE D 15 SHEET 1 DB 2 GLY D 34 GLY D 38 0 SHEET 2 DB 2 VAL D 69 LEU D 73 1 O VAL D 69 N VAL D 35 SHEET 1 DC 2 VAL D 132 GLN D 133 0 SHEET 2 DC 2 ILE D 136 VAL D 137 -1 O ILE D 136 N GLN D 133 SSBOND 1 CYS A 47 CYS A 151 1555 1555 2.04 SSBOND 2 CYS B 47 CYS B 151 1555 1555 2.04 SSBOND 3 CYS C 47 CYS C 151 1555 1555 2.04 SSBOND 4 CYS D 47 CYS D 151 1555 1555 2.04 CRYST1 75.870 75.870 193.254 90.00 90.00 120.00 P 31 2 1 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013180 0.007610 0.000000 0.00000 SCALE2 0.000000 0.015219 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005175 0.00000